For the first time, an expensive vaccine aimed at preventing cervical cancer in women has proven successful at preventing a disease in men, according to a study released Thursday by the vaccine’s ...

When a male patient with genital warts asks whether recurrences will continue, you may find yourself delivering some sobering news. Results from an analysis nested within the prospective, ...

The FDA has approved Gardasil (human papillomavirus quadrivalent [types 6, 11, 16, and 18] vaccine, recombinant, from Merck) for the prevention of genital warts caused by human papillomavirus (HPV) ...

A man has a 91% chance of contracting HPV at some point in his life. HPV contributes to 63% of penile cancers, over 90% of anal cancers, and 70% of oropharynx cancers. There are no testing guidelines ...

October 19, 2009 — The US Food and Drug Administration (FDA) has approved a new indication for a quadrivalent recombinant vaccine (Gardasil, Merck & Company, Inc) for the prevention of condyloma ...

Starting next month, male adolescents will also be able to receive the human papillomavirus (HPV) vaccine free of charge. As ...

HealthDay News — The current quadrivalent human papillomavirus (HPV) vaccine does not have a significant impact on the recurrence of genital warts in men exposed to HPV infection, according to ...

The Korea Disease Control and Prevention Agency (KDCA) announced on the 16th that it will support the national HPV ...

While most human papillomavirus (HPV) infection clears on its own, persistent HPV infection can cause genital warts and anal, penile and oropharyngeal cancers in men. Dr. Sadeep Shrestha, associate ...

A new study in JAMA Oncology shows that nearly half of all men in the U.S. have some type of human papillomavirus infection. HPV is a common sexually transmitted infection that is a major cause of ...

Genital warts are a sad and painful reality that some people have to deal with. You might already know about the normal skin warts that most people have, and they are not attractive either. But ...

WASHINGTON -- Drugmaker Merck said Friday that U.S. regulators cleared its vaccine Gardasil to prevent genital warts in young males, a new use for a product already approved to prevent cervical cancer ...